DK1636223T3 - Benzothiazolderivater som adenosinreceptorligander - Google Patents
Benzothiazolderivater som adenosinreceptorliganderInfo
- Publication number
- DK1636223T3 DK1636223T3 DK04732950T DK04732950T DK1636223T3 DK 1636223 T3 DK1636223 T3 DK 1636223T3 DK 04732950 T DK04732950 T DK 04732950T DK 04732950 T DK04732950 T DK 04732950T DK 1636223 T3 DK1636223 T3 DK 1636223T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor ligands
- adenosine receptor
- benzothiazole derivatives
- benzothiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03011039 | 2003-05-19 | ||
| PCT/EP2004/005178 WO2005000842A1 (en) | 2003-05-19 | 2004-05-14 | Benzothiazole derivatives as adenosine receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1636223T3 true DK1636223T3 (da) | 2008-06-23 |
Family
ID=33442729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04732950T DK1636223T3 (da) | 2003-05-19 | 2004-05-14 | Benzothiazolderivater som adenosinreceptorligander |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7371748B2 (da) |
| EP (1) | EP1636223B1 (da) |
| JP (1) | JP4444290B2 (da) |
| KR (1) | KR100859886B1 (da) |
| CN (1) | CN100528871C (da) |
| AR (1) | AR044362A1 (da) |
| AT (1) | ATE389652T1 (da) |
| AU (1) | AU2004251814B2 (da) |
| BR (1) | BRPI0410440A (da) |
| CA (1) | CA2524366C (da) |
| CL (1) | CL2004001067A1 (da) |
| CO (1) | CO5630031A2 (da) |
| DE (1) | DE602004012555T2 (da) |
| DK (1) | DK1636223T3 (da) |
| ES (1) | ES2301991T3 (da) |
| HK (1) | HK1092469A1 (da) |
| HR (1) | HRP20080207T3 (da) |
| IL (1) | IL171686A (da) |
| MX (1) | MXPA05012360A (da) |
| NO (1) | NO20055150L (da) |
| NZ (1) | NZ543074A (da) |
| PL (1) | PL1636223T3 (da) |
| PT (1) | PT1636223E (da) |
| RU (1) | RU2351597C2 (da) |
| SI (1) | SI1636223T1 (da) |
| TW (1) | TW200505882A (da) |
| WO (1) | WO2005000842A1 (da) |
| ZA (1) | ZA200509294B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008052930A2 (en) * | 2006-11-03 | 2008-05-08 | F. Hoffmann-La Roche Ag | Preparation of 4-alk0xy-7- (tetrahydropyran-4-yl) benzothiazol-2-amine derivatives |
| HRP20230251T1 (hr) * | 2017-08-01 | 2023-04-14 | Merck Patent Gmbh | Derivati tiazolopridina kao antagonisti adenozinskih receptora |
| WO2019038214A1 (en) | 2017-08-21 | 2019-02-28 | Merck Patent Gmbh | QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS |
| BR112020003594A2 (pt) * | 2017-08-21 | 2020-09-01 | Merck Patent Gmbh | derivados de benzimidazol como antagonistas de receptor de adenosina |
| WO2019141096A1 (zh) * | 2018-01-19 | 2019-07-25 | 四川科伦博泰生物医药股份有限公司 | 取代脲类化合物及其制备方法和用途 |
| JP2022505872A (ja) | 2018-10-25 | 2022-01-14 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | アデノシン受容体アンタゴニストとしての５－アザインダゾール誘導体 |
| AU2019363662A1 (en) | 2018-10-25 | 2021-03-25 | Merck Patent Gmbh | 5-azaindazole derivatives as adenosine receptor antagonists |
| AR117844A1 (es) | 2019-01-22 | 2021-09-01 | Merck Patent Gmbh | Derivados de tiazolopiridina como antagonistas del receptor de adenosina |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02012596A (es) * | 2000-06-21 | 2003-04-10 | Hoffmann La Roche | Derivados de benzotiazol. |
| MXPA04004982A (es) * | 2001-11-27 | 2004-08-11 | Hoffmann La Roche | Derivados de benzotiazol. |
| US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
| US6734179B2 (en) * | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
| PL378343A1 (pl) * | 2003-01-13 | 2006-03-20 | F. Hoffmann-La Roche Ag | Pochodne benzoksazolu i ich zastosowanie jako ligandów receptora adenozyny |
-
2004
- 2004-05-14 AU AU2004251814A patent/AU2004251814B2/en not_active Ceased
- 2004-05-14 JP JP2006529816A patent/JP4444290B2/ja not_active Expired - Fee Related
- 2004-05-14 TW TW093113590A patent/TW200505882A/zh unknown
- 2004-05-14 WO PCT/EP2004/005178 patent/WO2005000842A1/en active IP Right Grant
- 2004-05-14 DE DE602004012555T patent/DE602004012555T2/de not_active Expired - Lifetime
- 2004-05-14 AT AT04732950T patent/ATE389652T1/de active
- 2004-05-14 PT PT04732950T patent/PT1636223E/pt unknown
- 2004-05-14 ES ES04732950T patent/ES2301991T3/es not_active Expired - Lifetime
- 2004-05-14 MX MXPA05012360A patent/MXPA05012360A/es active IP Right Grant
- 2004-05-14 RU RU2005139527/04A patent/RU2351597C2/ru not_active IP Right Cessation
- 2004-05-14 EP EP04732950A patent/EP1636223B1/en not_active Expired - Lifetime
- 2004-05-14 BR BRPI0410440-4A patent/BRPI0410440A/pt not_active Application Discontinuation
- 2004-05-14 PL PL04732950T patent/PL1636223T3/pl unknown
- 2004-05-14 SI SI200430668T patent/SI1636223T1/sl unknown
- 2004-05-14 CA CA2524366A patent/CA2524366C/en not_active Expired - Fee Related
- 2004-05-14 NZ NZ543074A patent/NZ543074A/en unknown
- 2004-05-14 CN CNB2004800135624A patent/CN100528871C/zh not_active Expired - Fee Related
- 2004-05-14 DK DK04732950T patent/DK1636223T3/da active
- 2004-05-14 KR KR1020057021945A patent/KR100859886B1/ko active IP Right Grant
- 2004-05-17 AR ARP040101684A patent/AR044362A1/es not_active Application Discontinuation
- 2004-05-17 US US10/847,558 patent/US7371748B2/en not_active Expired - Fee Related
- 2004-05-17 CL CL200401067A patent/CL2004001067A1/es unknown
-
2005
- 2005-10-31 IL IL171686A patent/IL171686A/en active IP Right Grant
- 2005-11-03 NO NO20055150A patent/NO20055150L/no not_active Application Discontinuation
- 2005-11-16 CO CO05116289A patent/CO5630031A2/es not_active Application Discontinuation
- 2005-11-16 ZA ZA200509294A patent/ZA200509294B/en unknown
-
2006
- 2006-11-29 HK HK06113066.6A patent/HK1092469A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 HR HR20080207T patent/HRP20080207T3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1828167T3 (da) | Acrylamidderivater som antibiotiske midler | |
| ATE340782T1 (de) | Piperidinbenzolsulfonamidderivate | |
| NO20054136D0 (no) | Imidazol-4-yl-etynyl-pyridin-derivater | |
| ATE420066T1 (de) | Amidoacetonitrilderivate | |
| IS8180A (is) | Nýjar besímídasólafleiður | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
| ATE540935T1 (de) | Chinazolinderivate | |
| DK1611131T3 (da) | Pyrazolopyridin-derivater | |
| ATE352550T1 (de) | Chinazolinderivate | |
| DK1414440T3 (da) | N-phenylpyrrolguanidinderivater som melanocortinreceptorligander | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| DK1585749T3 (da) | Diazepinoindol-derivater som kinaseinhibitorer | |
| DK1802307T3 (da) | Pyrrolidinderivater som histamin-receptor-ligander | |
| NO20052866D0 (no) | Imidazokinolinderivater som adenosin A3 reseptorligander | |
| IS8364A (is) | N-þíasól-2-ýl-bensamíð afleiður | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| ATE306265T1 (de) | Benzothiazolderivate als adenosin-rezeptor- liganden | |
| IS8045A (is) | Púrín-6-ón-afleiður | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| ATE518848T1 (de) | 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate | |
| HK1092469A1 (en) | Benzothiazole derivatives as adenosine receptor ligands | |
| DK1740574T3 (da) | 4-amino-5-cyanopyrimidinderivater | |
| NO20043119L (no) | Triazolokinolinderivater som kan anvendes som adenosinreseptorligander |